RU98111594A - PHARMACEUTICAL COMPOSITIONS INCLUDING FLURBIPROFEN - Google Patents
PHARMACEUTICAL COMPOSITIONS INCLUDING FLURBIPROFENInfo
- Publication number
- RU98111594A RU98111594A RU98111594/14A RU98111594A RU98111594A RU 98111594 A RU98111594 A RU 98111594A RU 98111594/14 A RU98111594/14 A RU 98111594/14A RU 98111594 A RU98111594 A RU 98111594A RU 98111594 A RU98111594 A RU 98111594A
- Authority
- RU
- Russia
- Prior art keywords
- flurbiprofen
- throat
- sore throat
- chewed
- therapeutically effective
- Prior art date
Links
- SYTBZMRGLBWNTM-UHFFFAOYSA-N Flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 title claims 11
- 229960002390 flurbiprofen Drugs 0.000 title claims 11
- 239000008194 pharmaceutical composition Substances 0.000 title claims 3
- 206010068319 Oropharyngeal pain Diseases 0.000 claims 4
- 239000007909 solid dosage form Substances 0.000 claims 3
- 239000007921 spray Substances 0.000 claims 3
- 210000000214 Mouth Anatomy 0.000 claims 2
- 210000003800 Pharynx Anatomy 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
Claims (5)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9523833.3 | 1995-11-22 | ||
GBGB9523833.3A GB9523833D0 (en) | 1995-11-22 | 1995-11-22 | Medical treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
RU98111594A true RU98111594A (en) | 2000-05-20 |
RU2203655C2 RU2203655C2 (en) | 2003-05-10 |
Family
ID=10784245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU98111594/14A RU2203655C2 (en) | 1995-11-22 | 1996-11-21 | Agent and method for relieve of sick throat symptoms |
Country Status (21)
Country | Link |
---|---|
US (2) | US5889057A (en) |
EP (1) | EP0862424B1 (en) |
CN (1) | CN1148177C (en) |
AT (1) | ATE252382T1 (en) |
AU (1) | AU707749B2 (en) |
BG (1) | BG64166B1 (en) |
CA (1) | CA2238271C (en) |
CZ (1) | CZ289643B6 (en) |
DE (1) | DE69630460T2 (en) |
DK (1) | DK0862424T3 (en) |
ES (1) | ES2208768T3 (en) |
GB (1) | GB9523833D0 (en) |
HU (1) | HU225235B1 (en) |
IL (1) | IL124568A0 (en) |
NO (1) | NO317287B1 (en) |
NZ (1) | NZ322933A (en) |
PT (1) | PT862424E (en) |
RU (1) | RU2203655C2 (en) |
SK (1) | SK284092B6 (en) |
UA (1) | UA46807C2 (en) |
WO (1) | WO1997018802A1 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9523833D0 (en) * | 1995-11-22 | 1996-01-24 | Boots Co Plc | Medical treatment |
AU8107998A (en) * | 1997-05-22 | 1998-12-11 | Boots Company Plc, The | Pharmaceutical compositions |
AU7916798A (en) * | 1997-05-22 | 1998-12-11 | Boots Company Plc, The | Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat |
GB9710521D0 (en) * | 1997-05-22 | 1997-07-16 | Boots Co Plc | Process |
EP1206283A2 (en) * | 1999-05-17 | 2002-05-22 | Aesgen, Inc. | Improved cellular uptake of bioactive agents |
CA2406383A1 (en) * | 2000-04-13 | 2001-10-25 | Mayo Foundation For Medical Education And Research | A.beta.42 lowering agents |
CN1615135A (en) * | 2001-11-13 | 2005-05-11 | 法马西亚公司 | Oral dosage form of a sulfonamide prodrug such as parecoxib |
US20090035260A1 (en) * | 2002-07-29 | 2009-02-05 | Therapicon Srl | Enhanced nasal composition of active peptide |
CN1802152A (en) * | 2002-08-01 | 2006-07-12 | 艾斯根公司 | Improved treatment of cancer with glutamine |
EP1603548A4 (en) * | 2003-02-05 | 2007-10-10 | Myriad Genetics Inc | Method and composition for treating neurodegenerative disorders |
US20040265359A1 (en) * | 2003-04-17 | 2004-12-30 | Sacks Gordon S. | Oral delivery formulations of L-glutamine |
US20050042284A1 (en) * | 2003-07-11 | 2005-02-24 | Myriad Genetics, Incorporated | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease |
FR2865648B1 (en) * | 2004-02-03 | 2006-06-30 | Philippe Perovitch | METHOD FOR DIFFUSION OF INSOLUBLE MOLECULES IN AQUEOUS MEDIUM AND COMPOSITION IMPLEMENTING SAID METHOD |
ITMI20040235A1 (en) * | 2004-02-13 | 2004-05-13 | Therapicon Srl | PHARMACEUTICAL PREPARATION FOR THE ORAL CABLE |
WO2006001877A2 (en) * | 2004-04-13 | 2006-01-05 | Myriad Genetics, Inc. | Combination treatment for neurodegenerative disorders comprising r-flurbiprofen |
CN1946906A (en) * | 2004-04-29 | 2007-04-11 | 吉斯通护岸系统股份有限公司 | Veneers for walls, retaining walls and the like |
CA2618985A1 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
GB2423710A (en) * | 2005-03-01 | 2006-09-06 | Boots Healthcare Int Ltd | Lozenge production process |
CA2615063A1 (en) * | 2005-07-22 | 2007-02-01 | Myriad Genetics, Inc. | High drug load formulations and dosage forms |
KR20080034166A (en) * | 2005-11-02 | 2008-04-18 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same |
US7282224B1 (en) * | 2006-06-09 | 2007-10-16 | Guthy-Renker Corporation | Pain relief composition |
EP2046119A2 (en) * | 2006-07-07 | 2009-04-15 | Myriad Genetics, Inc. | Treatment of psychiatric disorders |
US7754234B2 (en) * | 2006-07-12 | 2010-07-13 | Jones Thomas L | Composition and method of treating a sore throat |
US20080107747A1 (en) * | 2006-10-23 | 2008-05-08 | Roederer Joy E | Pain relief composition |
US20090028802A1 (en) * | 2007-07-23 | 2009-01-29 | Toru Hibi | Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same |
JP5643297B2 (en) | 2009-05-19 | 2014-12-17 | ニューロデルム リミテッド | Composition for continuous administration of a dopa decarboxylase inhibitor |
IT1397132B1 (en) | 2009-12-01 | 2013-01-04 | Alfa Wassermann Spa | COMPOSITIONS INCLUDING NON-STEROID ANTI-INFLAMMATORS. |
ES2660772T3 (en) * | 2010-11-15 | 2018-03-26 | Neuroderm Ltd | Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions therefor |
GB201021267D0 (en) * | 2010-12-15 | 2011-01-26 | Reckitt Benckiser Healthcare Int Ltd | Novel pharmaceutical formulation |
CN107693486A (en) | 2012-06-05 | 2018-02-16 | 纽罗德姆有限公司 | Composition comprising apomorphine and organic acid and application thereof |
GB201216893D0 (en) | 2012-09-21 | 2012-11-07 | Aesica Pharmaceuticals Ltd | Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen |
EP3777833B1 (en) | 2014-03-13 | 2023-10-18 | Neuroderm Ltd. | Dopa decarboxylase inhibitor compositions |
US10258585B2 (en) | 2014-03-13 | 2019-04-16 | Neuroderm, Ltd. | DOPA decarboxylase inhibitor compositions |
CN110812331A (en) * | 2018-08-10 | 2020-02-21 | 北京普德康利医药科技发展有限公司 | Flurbiprofen pharyngeal retention particle |
US11213502B1 (en) | 2020-11-17 | 2022-01-04 | Neuroderm, Ltd. | Method for treatment of parkinson's disease |
US11844754B2 (en) | 2020-11-17 | 2023-12-19 | Neuroderm, Ltd. | Methods for treatment of Parkinson's disease |
US11331293B1 (en) | 2020-11-17 | 2022-05-17 | Neuroderm, Ltd. | Method for treatment of Parkinson's disease |
CN115536525B (en) * | 2022-09-23 | 2024-02-23 | 南京知和医药科技有限公司 | S- (+) -flurbiprofen salt and preparation method, pharmaceutical composition and application thereof |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1062721A (en) * | 1975-12-15 | 1979-09-18 | Anthony A. Sinkula | Propionic acid derivatives |
US4389393A (en) * | 1982-03-26 | 1983-06-21 | Forest Laboratories, Inc. | Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose |
JPH0647532B2 (en) * | 1983-08-31 | 1994-06-22 | ジ アツプジヨン カンパニ− | Treatment of alveolar bone resorption |
AU6656886A (en) * | 1985-12-16 | 1987-06-18 | Cilag A.G. | Pharmaceutical composition of suprofen |
WO1988003021A2 (en) * | 1986-10-22 | 1988-05-05 | The Upjohn Company | Treatment of gingivitis with ibuprofen or flurbiprofen |
JPS63156715A (en) * | 1986-12-19 | 1988-06-29 | Teisan Seiyaku Kk | Quick-acting slowly releasing agent |
JP2540581B2 (en) * | 1988-02-04 | 1996-10-02 | 三省製薬株式会社 | Topical |
US4931473A (en) * | 1989-02-15 | 1990-06-05 | Richardson-Vicks Inc. | Anesthetic oral compositions |
US5190981A (en) * | 1989-08-17 | 1993-03-02 | Sepracor Inc. | Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease |
ATE117892T1 (en) * | 1989-08-17 | 1995-02-15 | Sepracor Inc | ORAL S(+)-FLURBIPROFEN OR KETOPROFEN CONTAINING PRODUCT. |
JP2738092B2 (en) * | 1989-11-17 | 1998-04-08 | ライオン株式会社 | Oral composition |
JPH0426618A (en) * | 1990-05-21 | 1992-01-29 | Japan Tobacco Inc | Troche |
IT1243342B (en) * | 1990-07-13 | 1994-06-10 | Farcon Ag | ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES |
DE4028906A1 (en) * | 1990-09-12 | 1992-03-19 | Paz Arzneimittelentwicklung | MEDICINAL PRODUCTS AND THEIR PREPARATION AND THEIR USE IN THE CONTROL OF PAIN AND / OR DEFENSE AND / OR FEVER OF ANIMALS AND PEOPLE |
JPH07506839A (en) * | 1992-12-04 | 1995-07-27 | メイヤー・ファーマシューティカル・ラボラトリース・インコーポレーテッド | Sprayable analgesic compositions and methods of use thereof |
WO1994014476A1 (en) * | 1992-12-21 | 1994-07-07 | The Procter & Gamble Company | Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders |
US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
ES2211916T3 (en) * | 1994-09-02 | 2004-07-16 | Virginia Commonwealth University | COMPOSITION TO RELIEF PAIN, CONTAINING A NON-NARCORTIC ANALGESIC AND AN ANALGESIC POTENTIATOR. |
US5567733B1 (en) * | 1995-04-27 | 1999-08-24 | Jon G Dishler | Irritation relief using nonsteroidal anti-inflammatory compounds |
EP0837862A1 (en) * | 1995-07-05 | 1998-04-29 | The Procter & Gamble Company | Warming compounds |
GB9523833D0 (en) * | 1995-11-22 | 1996-01-24 | Boots Co Plc | Medical treatment |
US5955098A (en) * | 1996-04-12 | 1999-09-21 | Flemington Pharmaceutical Corp. | Buccal non polar spray or capsule |
ATE288255T1 (en) * | 1996-04-12 | 2005-02-15 | Novadel Pharma Inc | POLAR BUCCAL SPRAY |
-
1995
- 1995-11-22 GB GBGB9523833.3A patent/GB9523833D0/en active Pending
-
1996
- 1996-11-21 NZ NZ322933A patent/NZ322933A/en not_active IP Right Cessation
- 1996-11-21 PT PT96939925T patent/PT862424E/en unknown
- 1996-11-21 AT AT96939925T patent/ATE252382T1/en active
- 1996-11-21 DE DE69630460T patent/DE69630460T2/en not_active Expired - Lifetime
- 1996-11-21 RU RU98111594/14A patent/RU2203655C2/en active
- 1996-11-21 ES ES96939925T patent/ES2208768T3/en not_active Expired - Lifetime
- 1996-11-21 CA CA002238271A patent/CA2238271C/en not_active Expired - Fee Related
- 1996-11-21 WO PCT/EP1996/005208 patent/WO1997018802A1/en active IP Right Grant
- 1996-11-21 US US08/849,224 patent/US5889057A/en not_active Expired - Lifetime
- 1996-11-21 IL IL12456896A patent/IL124568A0/en not_active IP Right Cessation
- 1996-11-21 CZ CZ19981565A patent/CZ289643B6/en not_active IP Right Cessation
- 1996-11-21 UA UA98063236A patent/UA46807C2/en unknown
- 1996-11-21 SK SK665-98A patent/SK284092B6/en not_active IP Right Cessation
- 1996-11-21 DK DK96939925T patent/DK0862424T3/en active
- 1996-11-21 HU HU0000180A patent/HU225235B1/en not_active IP Right Cessation
- 1996-11-21 AU AU26119/97A patent/AU707749B2/en not_active Expired
- 1996-11-21 EP EP96939925A patent/EP0862424B1/en not_active Expired - Lifetime
- 1996-11-21 CN CNB96199729XA patent/CN1148177C/en not_active Expired - Lifetime
-
1998
- 1998-05-20 NO NO19982294A patent/NO317287B1/en not_active IP Right Cessation
- 1998-06-09 BG BG102526A patent/BG64166B1/en unknown
-
1999
- 1999-01-04 US US09/224,357 patent/US6166083A/en not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU98111594A (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING FLURBIPROFEN | |
EP0862424B1 (en) | Pharmaceutical compositions comprising flurbiprofen | |
ATE522211T1 (en) | STABILIZED FIBRATE MICROPARTICLES | |
GB9401892D0 (en) | Therapeutic agents | |
FI964593A (en) | Oral liquid alendronate compositions | |
DE69027216D1 (en) | TRANSMUCOSAL DOSAGE FORM | |
NZ508526A (en) | Opioid formulations for treating pain | |
CA2240717A1 (en) | Method of treating and diagnosing sleep disordered breathing and means for carrying out the method | |
SE8306367L (en) | ANTIDIURETICALLY EFFECTIVE PHARMACEUTICAL PREPARATION | |
RU95101385A (en) | Products containing g-csf and tnf-binding protein | |
US4387093A (en) | Arthritis treatment | |
RU2007133435A (en) | METHOD OF COMBINED TREATMENT AND APPLICABLE FOR THIS COMBINATION OF MEDICINES | |
RU93053489A (en) | PHARMACEUTICAL COMPOSITION OF ANTI-ALCOHOLIC, STIMULATING ENERGY METABOLISM, ACID-FORMING AND SECRETARY FUNCTION OF THE Mucous Stomach, RADIO PROTECTIVE AND ANTI-CHEMOLAR | |
HK94096A (en) | The use of certain calcium-citrate-malate for the manufacture of a medicament for the treatment of osteoporosis | |
IS4069A (en) | Prolonged-release tablets containing Naproxen | |
RU99119233A (en) | PHARMACEUTICAL COMPOSITIONS containing ibuprofen and domperidone for the treatment of migraine | |
ES2078251T3 (en) | SYSTEM FOR THE REGULATED DISTRIBUTION OF ACTIVE AGENTS AND PROCESS FOR THEIR PREPARATION. | |
CA2350396A1 (en) | A composition useful to treat periodontal disease | |
RU97120700A (en) | NEW PHARMACOLOGICAL APPLICATION OF ANTAGONISTS A-II RECEPTOR | |
CA2368352A1 (en) | Method for treating neurodegeneration | |
JP2000500159A (en) | Painkillers combined with melatonin | |
KR830008678A (en) | Analgesic composition | |
KR890001558A (en) | Zephyron and its pharmaceutically acceptable acid addition salts alleviate panic disorder | |
PT95867A (en) | Process for the preparation of a delayed-release composition comprising a lactide and glycolide copolymer, for treatment of periodontal diseases | |
SE8304818L (en) | MEDICINE WITH ANTICULAR, SPASMOLYTIC AND LOCAL ANESTIC EFFECTS |